← Company intelligence

Robot maker · early

Neuralink

Corporate marketmedicalCurated record

Neuralink designs and builds the R1 surgical robot in-house: a vision-guided neurosurgical system that inserts 64 flexible electrode threads (1024 electrodes), each thinner than a human hair, into the cortex with micron-scale precision while avoiding surface vasculature using real-time imaging — a task beyond human-hand capability. The N1 implant streams neural signals wirelessly and on-device/paired decoding models translate intent into cursor and device control. The CONVOY feasibility study (launched Nov 2024) extends N1 control to an investigational assistive robotic arm, making the implant a control interface for physical robots. All use is clinical-trial stage (PRIME, CONVOY, Blindsight); no commercial sales yet.

HeadquartersFremont, US
Founded2016
Corporate fundingNot disclosed
TeamNot listed
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries E
FoundersElon Musk (Co-Founder), Dongjin "DJ" Seo (Co-Founder & President), Max Hodak (Co-Founder, former President)
Regions servedNorth America, Europe, Middle East
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-21
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

R1 Surgical Robot

  • Robotically inserts 64 flexible electrode threads (1024 electrodes), each thinner than a human hair, into the cortex while avoiding surface vasculature using real-time imaging

    Precision autonomous neurosurgical thread insertion; the threads are too fine and flexible to be placed by a human hand

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordFounders FundSequoia CapitalThrive CapitalARK InvestVy CapitalDFJ Growth
TL

Company timeline

Milestones and announcements

2025-06-02Five individuals with severe paralysis reported using Neuralink implants to control digital and physical devicesFierce Biotech
2024-11-25CONVOY feasibility study launched to extend N1 implant control to an investigational assistive robotic armNeuralink
2024-01-29First human receives the N1 brain implant in the PRIME studyReuters
SC

Source ledger

6 unique public sources